Cited by 161Cytokine Signaling Pathways and InteractionsGenomics and Chromatin DynamicsNF-κB Signaling Pathways

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index; 10 of the 28 sources its claims cite were checked for support.

DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1

Open access

Abstract

Cytokine-dependent gene transcription greatly depends on the tyrosine phosphorylation (“activation”) of Stat proteins at the cell membrane. This rapidly leads to their accumulation in the nucleus by an unknown mechanism. We performed microinjections of recombinant Stat1 protein to show that nuclear accumulation of phosphorylated Stat1 can occur without cytokine stimulation of cells. Microinjection of Stat1 antibody and treatment of cells with kinase or phosphatase inhibitors revealed that nuclear accumulation is a highly dynamic process sustained by Stat1 nucleocytoplasmic cycling and continuous kinase activity. By characterizing nuclear accumulation mutants, it is demonstrated that nuclear import and nuclear retention are two separate steps leading up to nuclear accumulation, with nonspecific DNA binding of activated Stat1 being sufficient for nuclear retention. Critical for nuclear buildup of Stat1 and the subsequent nuclear export is the point of time of tyrosine dephosphorylation, because our data indicate that activated Stat1 is incapable of leaving the nucleus and requires dephosphorylation to do so. It is demonstrated that the inactivation of Stat1 is controlled by its exchange reaction with DNA, whereby DNA binding protects Stat1 from dephosphorylation in a sequence-specific manner. Thus, during nuclear accumulation, a surprisingly simple mechanism integrates central aspects of cytokine-dependent gene regulation, for example, receptor monitoring, promoter occupancy, and transcription factor inactivation.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This paper shows that tyrosine-phosphorylated Stat1 accumulates in the nucleus without cytokine receptor activation, and that nuclear accumulation is a dynamic process requiring continuous nucleocytoplasmic shuttling and kinase activity. DNA binding, especially nonspecific DNA binding, mediates nuclear retention and protects Stat1 from tyrosine dephosphorylation, thereby controlling the duration of nuclear accumulation.

Key findings

  • Microinjected tyrosine-phosphorylated Stat1 accumulated in the nucleus of untreated HeLa and U3A cells, whereas unphosphorylated Stat1 distributed pancellularly after ∼30 min and did not accumulate even after 3 h. Nuclear export required dephosphorylation: after nuclear injection, tyrosine-phosphorylated Stat1 remained nuclear at 6 h, while unphosphorylated Stat1 became almost pancellular.
  • Nuclear accumulation was dynamic: staurosporine caused complete Stat1 dephosphorylation after 60 min and collapse of nuclear accumulation, while vanadate/H₂O₂ suppressed dephosphorylation and extended accumulation. Cytoplasmic antibody injection depleted nuclear Stat1 in ∼30 min, but vanadate prevented this clearance, indicating continuous shuttling.
  • DNA binding controlled nuclear retention and inactivation. Stat1dna minus failed to accumulate in the nucleus despite unaltered import, whereas Stat1dna plus accumulated and bound specific and nonspecific DNA with almost equal avidity. DNA protected Stat1 from TC45 dephosphorylation in a concentration- and sequence-dependent manner; GAS sites protected better than unrelated DNA.
  • FRAP showed altered intranuclear mobility: after IFNγ, wild-type Stat1 recovery was ∼18.6 ± 3.2 sec, while Stat1dna plus was ∼206.7 ± 30.1 sec; with vanadate, wild-type was ∼46.4 ± 11.2 sec and dna plus ∼233.7 ± 46.6 sec. Stat1dna plus showed prolonged nuclear accumulation, Stat1dna off showed abbreviated accumulation, but neither dna plus nor dna minus induced a GAS-driven reporter in response to IFNγ.

Methods

  • Recombinant human Stat1 variants were purified from baculovirus-infected Sf9 cells, in vitro tyrosine-phosphorylated, and microinjected into HeLa and U3A cells. Cells were treated with IFNγ, staurosporine, leptomycin B, and vanadate/H₂O₂; antibody microinjection was used to probe nucleocytoplasmic shuttling.
  • DNA-binding mutants were generated by site-directed mutagenesis and analyzed by EMSA, biotinylated-oligonucleotide pull-down, coimmunoprecipitation, Western blotting, immunocytochemistry, and luciferase reporter assays.
  • In vitro dephosphorylation used purified TC45 phosphatase with or without GAS or mutant DNA. Intranuclear mobility was measured by FRAP, and immunofluorescence intensities were quantified with Student’s t-test or ANOVA/Tukey tests.

Limitations

  • The paper states no formal limitations section. It notes that nuclear dephosphorylation of recombinant Stat1 was slow compared with endogenous protein, which could be caused by the high concentration of injected material or by the absence of Arg31 methylation. It also notes that no data are available concerning nonspecific DNA binding of previously reported Stat1 mutants.
  • Evident from the text: conclusions rely heavily on microinjection, overexpression, and purified in vitro systems, which may not fully reproduce endogenous chromatin and cellular contexts. FRAP sample sizes are small (n = 4–12 per condition), and mutant proteins could have effects beyond altered DNA binding.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1101/gad.268003

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

10 of 28 cited sources checked · 8 supported · 0 flagged · accuracy not yet measured

Show all 84 claims

  • It may state two separate claims as one. 43
  • Probably not a substantial claim. 14
52 of 52
  • The paper relies on this without support.

    Recombinant Stat1 protein purified from baculovirus-infected Sf9 cells and microinjected into cells is correctly folded and functionally equivalent to endogenous Stat1.

    “To investigate nuclear translocation, we purified the human Stat1 protein from baculovirus-infected Sf9 cells (Fig. 1A).”
    “These proteins were microinjected into HeLa cells and the cell line U3A (data not shown), which does not express Stat1 (Müller et al. 1993).”
  • The paper relies on this without support.

    In vitro dephosphorylation of recombinant Stat1 by TC45 reflects the in vivo dephosphorylation and inactivation of Stat1.

    “At first we therefore examined the influence of DNA binding on the dephosphorylation of Stat1 variants in vitro.”
    “In conjunction with the in vitro dephosphorylation data, we conclude that the release of Stat1 from DNA did not require enzymatic activity.”
2 of 2

Citations

Cites

Flagged first, then by citations

Show all 48 references

Cited by

Sorted by citations

Items 101–161 of 161

Metadata

Authors
Meyer, T., Marg, A., Lemke, P., Wiesner, B., & Vinkemeier, U.
Affiliations
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (DE)
Corresponding author
Vinkemeier, Uwe
Venue
Genes & Development
Published
2003-08-15
Volume
17
Issue
16
Pages
1992-2005
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2099132542
Cited by
161
References
48
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 4 · 2014: 9 · 2013: 9 · 2012: 7
Type
posted content
Language
en
Open access
Locations
  • Genes & Development (publishedVersion)
  • PubMed (publishedVersion)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion)
  • Europe PMC (PubMed Central) (submittedVersion)
  • PubMed Central (submittedVersion)
Funders
  • Israel Cancer Research Fund
  • Bundesministerium für Bildung und Forschung
  • Université de Strasbourg
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
STAT1, DNA binding, tyrosine phosphorylation, tyrosine dephosphorylation, nucleocytoplasmic shuttling, nuclear import, nuclear retention, nuclear export, transcription factor inactivation, sequence-specific DNA binding, phosphatase activity
MeSH terms
Antibodies, Monoclonal, Cell Nucleus, Cytoplasm, DNA, DNA-Binding Proteins, Enzyme Inhibitors, HeLa Cells, Humans, Interferon-gamma, Models, Biological, Mutation, Phosphorylation, Recombinant Proteins, Transcription, Genetic, Tumor Cells, Cultured, Tyrosine, Vanadates, Transcriptional Activation, Trans-Activators, Active Transport, Cell Nucleus, STAT1 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-23, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-23 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review